| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.21 | 0.0003 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.15 | 0.0009 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.17 | 0.001 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |